UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] RSS 2.0 [feed] RSS 1.0 [feed] Atom
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | V | W | Y | Z
Number of items: 350.


Adams, MJ; Cardigan, RA; Marchant, WA; Grocott, MPW; Mythen, MG; Mutch, M; ... Machin, SJ; + view all (2002) Tissue factor pathway inhibitor antigen and activity in 96 patients receiving heparin for cardiopulmonary bypass. J CARDIOTHOR VASC AN , 16 (1) 59 - 63. 10.1053/jcan.2002.29677.

Aligianis, IA; Forshew, T; Johnson, S; Michaelides, M; Johnson, CA; Trembath, RC; ... Maher, ER; + view all (2002) Mapping of a novel locus for achromatopsia (ACHM4) to 1p and identification of a germline mutation in the alpha subunit of cone transducin (GNAT2). J MED GENET , 39 (9) 656 - 660.

Allcock, RJN; Atrazhev, AM; Beck, S; de Jong, PJ; Elliott, JF; Forbes, S; ... Williams, S; + view all (2002) The MHC haplotype project: A resource for HLA-linked association studies. TISSUE ANTIGENS , 59 (6) 520 - 521.

Ancliff, PJ; Gale, RE; Somerville, TC; Kwaja, A; Liesner, R; Hann, IM; Linch, DC; (2002) Complete inhibition of neutrophil elastase fails to correct the in vitro phenotype of severe congenital neutropenia. In: BLOOD. (pp. 243A - 243A). AMER SOC HEMATOLOGY

Ancliff, PJ; Gale, RE; Watts, MJ; Liesner, R; Hann, IM; Strobel, S; Linch, DC; (2002) Paternal mosaicism proves the pathogenic nature of mutations in neutrophil elastase in severe congenital neutropenia. BLOOD , 100 (2) 707 - 709.

Ansell, SM; Arendt, BK; Grote, DM; Jelinek, DF; Novak, AJ; Wellik, LE; ... Fielding, A; + view all (2002) Inhibition of survivin expression suppresses the growth of transformed large cell non-Hodgkin lymphoma. In: BLOOD. (pp. 352A - 352A).

Antoniou, AN; Ford, S; Pilley, ES; Blake, N; Powis, SJ; (2002) Interactions formed by individually expressed TAP1 and TAP2 polypeptide subunits. IMMUNOLOGY , 106 (2) 182 - 189.

Antoniou, AN; Moore, N; Dyson, PJ; (2002) Remodelling of the S3 PA700 proteasome activator gene chromatin structure during thymocyte differentiation. IMMUNOGENETICS , 54 (4) 260 - 267. 10.1007/s00251-002-0475-3.

Antoniou, AN; Watts, C; (2002) Antibody modulation of antigen presentation: positive and negative effects on presentation of the tetanus toxin antigen via the murine B cell isoform of Fc gamma RII. EUR J IMMUNOL , 32 (2) 530 - 540.

Arcaro, A; Khanzada, UK; Vanhaesebroeck, B; Tetley, TD; Waterfield, MD; Seckl, MJ; (2002) Two distinct phosphoinositide 3-kinases mediate polypeptide growth factor-stimulated PKB activation. EMBO J , 21 (19) 5097 - 5108.

Ardeshna, KM; Pizzey, AR; Walker, SJ; Devereux, S; Khwaja, A; (2002) The upregulation of CC chemokine receptor 7 and the increased migration of maturing dendritic cells to macrophage inflammatory protein 3 beta and secondary lymphoid chemokine is mediated by the p38 stress-activated protein kinase pathway. BRIT J HAEMATOL , 119 (3) 826 - 829.

Arkenau, H-T; Widjaja, A; (2002) Ein seltener fall von cholestase und makrohämaturie bei einem 52-jährigen patienen. Medizinische Klinik , 97 (8) 480 - 483. 10.1007/s00063-002-1183-3.

Arkenau, HT; Stichtenoth, DO; Frölich, JC; Manns, MP; Böker, KH; (2002) Elevated nitric oxide levels in patients with chronic liver disease and cirrhosis correlate with disease stage and parameters of hyperdynamic circulation. Z Gastroenterol , 40 (11) 907 - 913. 10.1055/s-2002-35413.

Arkenau, HT; Widjaja, A; (2002) [A rare case of cholestasis and macrohematuria in a 52-year-old patient]. Med Klin (Munich) , 97 (8) 480 - 483.

Attygalle, A; Al-Jehani, R; Diss, TC; Munson, P; Liu, H; Du, MQ; ... Dogan, A; + view all (2002) Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10. Blood , 99 (2) 627 - 633.

Attygalle, AD; Al-Jehani, R; Diss, TC; Munson, P; Liu, H; Du, MQ; ... Dogan, A; + view all (2002) Characterisation of T-cells expressing CD10 in angioimmunoblastic T-cell lymphoma. MODERN PATHOL , 15 (1) 229A - 230A.

Attygalle, AD; Al-Jehani, R; Diss, TC; Munson, P; Liu, H; Du, MQ; ... Dogan, A; + view all (2002) Characterisation of T-cells expressing CD10 in angioimmunoblastic T-cell lymphoma. LAB INVEST , 82 (1) 229A - 230A.

Avivi, I; Bacon, CM; Obermann, EC; Quian, WD; Smith, P; Linch, DC; Dogan, A; (2002) Histological and clinical prognostic factors in follicular lymphoma: Proposal for a prognostic model. In: BLOOD. (pp. 37A - 37A). AMER SOC HEMATOLOGY

Avivi, I; Kyriakou, C; Kottaridis, PD; Chakrabarti, S; Goldstone, AH; Mackinnon, S; (2002) Neurological complications post low intensity bone marrow transplantation. In: BLOOD. (pp. 412A - 412A). AMER SOC HEMATOLOGY


Baraldi, PG; Romagnoli, R; Guadix, AE; de las Infantas, MJP; Gallo, MA; Espinosa, A; ... Hartley, JA; + view all (2002) Design, synthesis, and biological activity of hybrid compounds between uramustine and DNA minor groove binder distamycin A. J MED CHEM , 45 (17) 3630 - 3638. 10.1021/jm011113b.

Baraldi, PG; Romagnoli, R; Pavani, MG; Nunez, MD; Bingham, JP; Hartley, JA; (2002) Benzoyl and cinnamoyl nitrogen mustard derivatives of benzoheterocyclic analogues of the tallimustine: Synthesis and antitumour activity. BIOORGAN MED CHEM , 10 (5) 1611 - 1618.

Barker, KT; Bevan, S; Wang, R; Lu, YJ; Flanagan, AM; Bridge, JA; ... Houlston, RS; + view all (2002) Low frequency of somatic mutations in the FH/multiple cutaneous leiomyomatosis gene in sporadic leiomyosarcomas and uterine leiomyomas. BRIT J CANCER , 87 (4) 446 - 448. 10.1038/sj.bjc.6600502.

Baselga, J; Rischin, D; Ranson, M; Calvert, H; Raymond, E; Kieback, DG; ... Albanell, J; + view all (2002) Phase I safety, pharmacokinetic, and pharmacodynamic trial of ZD1839, a selective oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with five selected solid tumor types. J CLIN ONCOL , 20 (21) 4292 - 4302. 10.1200/JCO.2002.03.100.

Bates, AW; (2002) Conjoined twins in the 16th century. TWIN RES , 5 (6) 521 - 528.

Bates, AW; (2002) Documentary evidence for conjoined twins in the sixteenth century. AM J MED GENET , 112 (4) 430 - 431. 10.1002/ajmg.10749.

Bates, AW; Baithun, SI; (2002) Secondary solid neoplasms of the prostate: a clinico-pathological series of 51 cases. VIRCHOWS ARCH , 440 (4) 392 - 396. 10.1007/s004280100505.

Bates, AW; Baithun, SI; (2002) Secondary tumours of the penis. J ROY SOC MED , 95 (3) 162 - 163.

Bates, AW; Baithun, SI; (2002) The significance of secondary neoplasms of the urinary and male genital tract. VIRCHOWS ARCH , 440 (6) 640 - 647. 10.1007/s00428-001-0549-x.

Bates, AW; Hall, CM; Morgan, H; Rosser, EM; Scheimberg, I; (2002) Lethal acrofacial dysostosis, pre- and post-axial defects of the hands, and bilateral renal agenesis. CLIN DYSMORPHOL , 11 (1) 63 - 66.

Batey, MA; Wright, JG; Azzabi, A; Newell, DR; Lind, MJ; Calvert, AH; Boddy, AV; (2002) Population pharmacokinetics of adjuvant cyclophosphamide, methotrexate and 5-fluorouracil (CMF). EUR J CANCER , 38 (8) 1081 - 1089.

Beauregard, DA; Pedley, RB; Hill, SA; Brindle, KM; (2002) Differential sensitivity of two adenocarcinoma xenografts to the anti-vascular drugs combretastatin A4 phosphate and 5,6-dimethylxanthenone-4-acetic acid, assessed using MRI and MRS. NMR BIOMED , 15 (2) 99 - 105. 10.1002/nbm.723.

Bellan, C; Lazzi, S; Zazzi, M; Lalinga, AV; Palummo, N; Galieni, P; ... Tosi, P; + view all (2002) Immunoglobulin gene rearrangement analysis in composite hodgkin disease and large B-cell lymphoma: evidence for receptor revision of immunoglobulin heavy chain variable region genes in Hodgkin-Reed-Sternberg cells? Diagn Mol Pathol , 11 (1) 2 - 8.

Belorgey, D; Crowther, DC; Mahadeva, R; Lomas, DA; (2002) Mutant Neuroserpin (S49P) that causes familial encephalopathy with neuroserpin inclusion bodies is a poor proteinase inhibitor and readily forms polymers in vitro. J Biol Chem , 277 (19) 17367 - 17373. 10.1074/jbc.M200680200. Gold open access

Bernardi, R; Grisendi, S; Salomoni, P; Scaglioni, PP; Pandolfi, PP; (2002) The promyelocytic leukemia protein, PML, localizes to the nucleolus after DNA damage, interacts with Mdm2 and promotes p53 stability. In: BLOOD. (pp. 31A - 32A). AMER SOC HEMATOLOGY

Bernassola, F; Salomoni, P; Di Como, C; Pagano, N; Melino, G; Pandolfi, PP; (2002) PML enhances p73 transcriptional activity and biological functions by preventing its proteasome-dependent degradation. In: BLOOD. (pp. 177B - 177B). AMER SOC HEMATOLOGY

Bernstein, HG; Heinemann, A; Krell, D; Mawrin, C; Bielau, H; Danos, P; ... Baumann, B; + view all (2002) Further immunohistochemical evidence for impaired NO signaling in the hypothalamus of depressed patients. Ann N Y Acad Sci , 973 91 - 93.

Best, JL; Ganiatsas, S; Agarwal, S; Changou, A; Salomoni, P; Shirihai, O; ... Zon, LI; + view all (2002) SUMO-1 protease-1 regulates gene transcription through PML. MOL CELL , 10 (4) 843 - 855.

Biganzoli, L; Cufer, T; Bruning, P; Coleman, R; Duchateau, L; Calvert, AH; ... Piccart, MJ; + view all (2002) Doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as first-line chemotherapy in metastatic breast cancer: The European Organization for Research and Treatment of Cancer 10961 multicenter phase III trial. J CLIN ONCOL , 20 (14) 3114 - 3121. 10.1200/JCO.2002.11.005.

Bowen, RL; Francis, RJ; Green, AJ; Baig, S; Knell, V; Buscombe, JR; ... Begent, RHJ; + view all (2002) How accurately can the oncologist report FDG-PET tumour response using the ADAC vertex plus dual-headed gamma camera? BRIT J CANCER , 86 S102 - S102.

Branson, K; Chopra, R; Kottaridis, PD; McQuaker, G; Parker, A; Schey, S; ... Mackinnon, S; + view all (2002) Role of nonmyeloablative allogeneic stem-cell transplantation after failure of autologous transplantation in patients with lymphoproliferative malignancies. J CLIN ONCOL , 20 (19) 4022 - 4031. 10.1200/JCO.2002.11.088.

Brett, PJ; Tiwana, H; Feavers, IM; Charalambous, BM; (2002) Characterization of oligopeptides that cross-react with carbohydrate-specific antibodies by real time kinetics, in-solution competition enzyme-linked immunosorbent assay, and immunological analyses. J BIOL CHEM , 277 (23) 20468 - 20476. 10.1074/jbc.M200387200. Gold open access

Broceño, C; Wilkie, S; Mittnacht, S; (2002) RB activation defect in tumor cell lines. Proc Natl Acad Sci U S A , 99 (22) 14200 - 14205. 10.1073/pnas.212519499.

Brock, CS; Lee, SM; (2002) Anti-angiogenic strategies and vascular targeting in the treatment of lung cancer. Eur Respir J , 19 (3) 557 - 570.

Budhram-Mahadeo, V; Morris, P; Ndisang, D; Irshad, S; Lozano, G; Pedley, B; Latchman, DS; (2002) The Brn-3a POU family transcription factor stimulates p53 gene expression in human and mouse tumour cells. NEUROSCI LETT , 334 (1) 1 - 4.

Bunn, PA; Calvert, H; (2002) Pemetrexed, a novel multitargeted antifolate: Current development and future directions - Introduction. SEMIN ONCOL , 29 (2) 1 - 2. 10.1053/sonc.2002.30757.

Burcombe, RJ; Makris, A; Pittam, M; Lowe, J; Emmott, J; Wong, WL; (2002) Evaluation of good clinical response to neoadjuvant chemotherapy in primary breast cancer using [F-18]- fluorodeoxyglucose positron emission tomography. European Journal of Cancer , 38 (3) 375 - 379.

Byrne, E; (2002) Autoimmune myasthenia gravis: place of thymectomy and preferredtechnique. Internal Medicine Journal , 32 (8) 365 - 366.

Byrne, E; (2002) Does mitochondrial respiratory chain dysfunction have a role in common neurodegenerative disorders? Journal of Clinical Neuroscience , 9 (5) 497 - 501.


Calvert, AH; Egorin, MJ; (2002) Carboplatin dosing formulae: gender bias and the use of creatinine-based methodologies. EUR J CANCER , 38 (1) 11 - 16.

Calvert, H; (2002) Folate status and the safety profile of antifolates. SEMINARS IN ONCOLOGY , 29 (2) 3 - 7. 10.1053/sonc.2002.30761.

Calvert, H; Bunn, PA; (2002) Future directions in the development of pemetrexed. SEMINARS IN ONCOLOGY , 29 (2) 54 - 61. 10.1053/sonc.2002.30761.

Calvert, H; Jodrell, DI; Cassidy, J; Harris, AL; (2002) Efficacy, safety, and cost of new anticancer drugs - Pessimistic conclusion was not justified. BRIT MED J , 325 (7375) 1302 - 1303.

Carrell, RW; Lomas, DA; (2002) Alpha1-antitrypsin deficiency--a model for conformational diseases. N Engl J Med , 346 (1) 45 - 53. 10.1056/NEJMra010772.

Casey, JL; Napier, MP; King, DJ; Pedley, RB; Chaplin, LC; Weir, N; ... Begent, RH; + view all (2002) Tumour targeting of humanised cross-linked divalent-Fab' antibody fragments: a clinical phase I/II study. Br J Cancer , 86 (9) 1401 - 1410. 10.1038/sj.bjc.6600198.

Casey, JL; Napier, MP; King, DJ; Pedley, RB; Chaplin, LC; Weir, N; ... Begent, RHJ; + view all (2002) Tumour targeting of humanised cross-linked divalent-fab ' antibody fragments: a clinical phase I/II study. BRIT J CANCER , 86 (9) 1401 - 1410. 10.1038/sj/bjc/6600198.

Chakrabarti, S; Avivi, I; Mackinnon, S; Ward, K; Kottaridis, PD; Osman, H; ... Milligan, DW; + view all (2002) Respiratory virus infections in transplant recipients after reduced-intensity conditioning with Campath-1H: high incidence but low mortality. BRIT J HAEMATOL , 119 (4) 1125 - 1132.

Chakrabarti, S; Mackinnon, S; Chopra, R; Kottaridis, PD; Peggs, K; O'Gorman, P; ... Milligan, DW; + view all (2002) High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution. BLOOD , 99 (12) 4357 - 4363.

Chakraverty, R; Peggs, K; Chopra, R; Milligan, DW; Kottaridis, PD; Verfuerth, S; ... Mackinnon, S; + view all (2002) Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen. BLOOD , 99 (3) 1071 - 1078.

Chantret, I; Dupré, T; Delenda, C; Bucher, S; Dancourt, J; Barnier, A; ... Moore, SE; + view all (2002) Congenital disorders of glycosylation type Ig is defined by a deficiency in dolichyl-P-mannose:Man7GlcNAc2-PP-dolichyl mannosyltransferase. J Biol Chem , 277 (28) 25815 - 25822. 10.1074/jbc.M203285200. Gold open access

Chatterjee, R; KOTTARIDIS, PD; McGarrigle, HH; Linch, DC; (2002) Management of erectile dysfunction by combination therapy with testosterone and sildenafil in recipients of high-dose therapy for haematological malignancies. Bone Marrow Transplantation (607) 610 - ?.

Chatterjee, R; Kottaridis, PD; McGarrigle, HH; Linch, DC; (2002) Management of erectile dysfunction by combination therapy with testosterone and sildenafil in recipients of high-dose therapy for haematological malignancies. Bone Marrow Transplant , 29 (7) 607 - 610. 10.1038/sj.bmt.1703421.

Chatterjee, R; Kottaridis, PD; McGarrigle, HH; Linch, DC; (2002) Post-transplant complications - Management of erectile dysfunction by combination therapy with testosterone and sildenafil in recipients of high-dose therapy for haematological malignancies. BONE MARROW TRANSPL , 29 (7) 607 - 610. 10.1038/sj/bmt/1703421.

Chow, E; Wu, JSY; Hoskin, P; Coia, LR; Bentzen, SM; Blitzer, PH; (2002) International consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases. Radiotherapy And Oncology , 64 (3) 275 - 280.

Clark, FJ; Chakraverty, R; (2002) Role of dendritic cells in graft-versus-host disease. J HEMATOTH STEM CELL , 11 (4) 601 - 616.

Colledge, L; Bennett, CL; Reay, PA; Blackburn, CC; (2002) Rapid constitutive generation of a specific peptide-MHC class II complex from intact exogenous protein in immature murine dendritic cells. Eur J Immunol , 32 (11) 3246 - 3255. 10.1002/1521-4141(200211)32:11<3246::AID-IMMU3246>3.0.CO;2-B.

Colombari, R; Togni, R; Furlanetto, A; Quaglia, A; Dhillon, A; Demichelis, F; ... Dhillon, AP; + view all (2002) Royal free (RFH) scoring system for unifocal hepatocellular carcinoma (HCC) < 5 cm diameter: A valuable prognostic tool. J HEPATOL , 36 78 - 78.

Colombo, E; Marine, JC; Danovi, D; Falini, B; Pelicci, PG; (2002) Nucleophosmin regulates the stability and transcriptional activity of p53. NAT CELL BIOL , 4 (7) 529 - 533. 10.1038/ncb814.

Conde, L; Mateos, A; Herrero, J; Dopazo, J; (2002) Unsupervised reduction of the dimensionality followed by supervised learning with a perceptron improves the classification of conditions in DNA microarray gene expression data. In: NEURAL NETWORKS FOR SIGNAL PROCESSING XII, PROCEEDINGS. (pp. 77 - 86).

Cooke, SP; Pedley, RB; Boden, R; Begent, RHJ; Chester, KA; (2002) In vivo tumor delivery of a recombinant single chain fv :: tumor necrosis factor-alpha fusion protein (vol 13, pg 7, 2002). BIOCONJUGATE CHEM , 13 (2) 385 - 385. 10.1021/bc020015h.

Cooke, SP; Pedley, RB; Boden, R; Begent, RHJ; Chester, KA; (2002) In vivo tumor delivery of a recombinant single-chain Fv::Tumor necrosis factor: A fusion protein. BIOCONJUGATE CHEM , 13 (1) 7 - 15. 10.1021/bc000178a.

Cox, ST; Ogilvie, H; Bohan, EM; Holman, R; Prentice, HG; Potter, M; ... Little, AM; + view all (2002) Sequence of two new HLA-Cw alleles: HLA-Cw*0313 and HLA-Cw*1208. Tissue Antigens , 59 (1) 49 - 51.

Craddock, C; Hochhauser, D; (2002) Realising the potential of targeted therapies in oncology. LANCET , 360 (9331) 424 - 425.

Crawley, C; Lalanacette, M; Szydlo, R; Gilleece, M; Juliusson, G; Michallet, M; ... Apperley, JF; + view all (2002) Reduced intensity conditioned allografts for myeloma: A study from the Chronic Leukaemia Working Party of the EBMT. In: BLOOD. (pp. 144A - 144A). AMER SOC HEMATOLOGY

Crotaz, GR; Solanki, C; Ballinger, JR; Parmar, JS; Lomas, DA; Chilvers, ER; (2002) A novel method of radiolabelling alpha(1)-antitrypsin monomer and polymers. JOURNAL OF NUCLEAR MEDICINE , 43 (5) , Article UNSP 200192.


Davidoff, AM; Nathwani, AC; Spurbeck, WW; Ng, CY; Zhou, J; Vanin, EF; (2002) rAAV-mediated long-term liver-generated expression of an angiogenesis inhibitor can restrict renal tumor growth in mice. Cancer Res , 62 (11) 3077 - 3083.

Davies, H; Bignell, GR; Cox, C; Stephens, P; Edkins, S; Clegg, S; ... Futreal, PA; + view all (2002) Mutations of the BRAF gene in human cancer. Nature , 417 (6892) 949 - 954. 10.1038/nature00766.

Davies, JK; Koh, MB; Prentice, HG; Lowdell, MW; (2002) Selective allodepletion by immunomagnetic sorting can reduce alloreactivity in vitro, can be done at a clinical scale and preserves in vitro activity against CMV and EBV. BONE MARROW TRANSPL , 29 S45 - S46.

Davis, BA; Porter, JB; (2002) Results of long term iron chelation treatment with deferoxamine. ADV EXP MED BIOL , 509 91 - 125.

Davis, RL; Shrimpton, AE; Carrell, RW; Lomas, DA; Gerhard, L; Baumann, B; ... Holohan, PD; + view all (2002) Association between conformational mutations in neuroserpin and onset and severity of dementia. Lancet , 359 (9325) 2242 - 2247. 10.1016/S0140-6736(02)09293-0.

De Silva, IU; McHugh, PJ; Clingen, PH; Hartley, JA; (2002) Defects in interstrand cross-link uncoupling do not account for the extreme sensitivity of ERCC1 and XPF cells to cisplatin. NUCLEIC ACIDS RES , 30 (17) 3848 - 3856. Gold open access

Delenda, C; Audit, M; Danos, O; (2002) Biosafety issues in lentivector production. Curr Top Microbiol Immunol , 261 123 - 141.

Diatloff-Zito, C; Marquis, E; Nicole, A; Labit, H; Junien, C; Robert, JJ; (2002) Altered DNA methylation pattern in the transient neonatal diabetes determined by the genomic sequencing method. In: AMERICAN JOURNAL OF HUMAN GENETICS. (pp. 175 - 175). UNIV CHICAGO PRESS

Diss, TC; Liu, HX; Du, MQ; Isaacson, PG; (2002) Improvements to B-cell clonality analysis using PCR amplification of immunoglobin light chain genes. Molecular Pathology , 55 (2) 98 - 101.

Donohoe, S; Quenby, S; Mackie, I; Panal, G; Farquharson, R; Malia, R; ... Machin, S; + view all (2002) Fluctuations in levels of antiphospholipid antibodies and increased coagulation activation markers in normal and heparin-treated antiphospholipid syndrome pregnancies. LUPUS , 11 (1) 11 - 20. 10.1191/0961203302lu132oa.

Du, MQ; Isaacson, PG; (2002) Gastric MALT lymphoma: from aetiology to treatment. The Lancet Oncology , 3 97 - 104.

Duarte, RF; Chen, FE; Lowdell, M; Lamana, ML; Potter, M; Bueren, JA; ... Madrigal, JA; + view all (2002) Mechanisms of functional impairment of T lymphocytes following polyclonal expansion for retrovirally mediated gene transfer. TISSUE ANTIGENS , 59 66 - 66.

Duarte, RF; Chen, FE; Lowdell, MW; Potter, MN; Lamana, ML; Prentice, HG; Madrigal, JA; (2002) Functional impairment of human T-lymphocytes following PHA-induced expansion and retroviral transduction: implications for gene therapy. GENE THER , 9 (20) 1359 - 1368. 10.1038/sj.gt.3301807.

Dunne, C; Little, AM; Cox, ST; Masson, D; Crowley, J; Barnes, T; ... Madrigal, JA; + view all (2002) Identification and nucleotide sequence of a new null allele, HLA B*3540N. Tissue Antigens , 59 (6) 522 - 524.


El-Emir, E; Petrie, IA; Boxer, GM; Boden, R; Dearling, JLJ; Raleigh, JA; ... Pedley, RB; + view all (2002) Tumour parameters affected by combretastatin A-4 phosphate therapy in a human colorectal xenograft model in nude mice. BRIT J CANCER , 86 S112 - S112.

Emery, VC; Hassan-Walker, AF; (2002) Focus on new drugs in development against human cytomegalovirus. DRUGS , 62 (13) 1853 - 1858.

Enver, T; Brown, J; Bruno, L; Gale, K; Gupta, R; Heyworth, C; ... Sarno, S; + view all (2002) Transcriptional programming in haematopoietic stem cells. EXP HEMATOL , 30 (6) 37 - 37.

Enver, T; Brown, J; Bruno, L; Gupta, R; Heyworth, C; Hoffmann, R; ... Seidl, T; + view all (2002) Dynamic analysis of stem cell self renewal and differentiation using global gene expression profiling. In: BLOOD. (pp. 721A - 721A). AMER SOC HEMATOLOGY

Ezoe, S; Matsumura, I; Nakata, S; Gale, K; Ishihara, K; Minegishi, N; ... Kanakura, Y; + view all (2002) GATA-2/estrogen receptor chimera regulates cytokine-dependent growth of hematopoietic cells through accumulation of p21(WAF1) and p27(Kip1) proteins. BLOOD , 100 (10) 3512 - 3520.

Ezoe, S; Matsumura, I; Shibayama, H; Satoh, Y; Enver, T; Kanakura, Y; (2002) GATA-1 and GATA-2 inhibit cytokine-dependent growth of hematopoietic cells through the inhibition of MAPK activities. In: BLOOD. (pp. 522A - 523A). AMER SOC HEMATOLOGY


Fielding, A; (2002) Cancer vaccines: unanswered questions. May 16, 2002, Phacilitate Spring Vaccine Forum, Cancer Vaccines, Paris, France. Expert Rev Vaccines , 1 (2) 131 - 133. 10.1586/14760584.1.2.131.

Fielding, A; Bucheit, A; Kumar, S; Yu, L; von Messling, V; (2002) Replicating attenuated measles virus can be engineered to enter cells through the CD20 antigen. In: BLOOD. (pp. 201A - 202A).

Fielding, A; Grote, D; Cattaneo, R; (2002) The anti-lymphoma efficacy of replicating, attenuated measles virus is enhanced by viral expression of GM-CSF. In: BLOOD. (pp. 578A - 578A).

Firat, H; Cochet, M; Rohrlich, PS; Garcia-Pons, F; Darche, S; Danos, O; ... Langlade-Demoyen, P; + view all (2002) Comparative analysis of the CD8(+) T cell repertoires of H-2 class I wild-type/HLA-A2.1 and H-2 class I knockout/HLA-A2.1 transgenic mice. Int Immunol , 14 (8) 925 - 934.

Firat, H; Zennou, V; Garcia-Pons, F; Ginhoux, F; Cochet, M; Danos, O; ... Charneau, P; + view all (2002) Use of a lentiviral flap vector for induction of CTL immunity against melanoma. Perspectives for immunotherapy. J Gene Med , 4 (1) 38 - 45.

Flynn, AA; Green, AJ; Pedley, RB; Boxer, GM; Dearling, J; Watson, R; ... Begent, RH; + view all (2002) A model-based approach for the optimization of radioimmunotherapy through antibody design and radionuclide selection. Cancer , 94 (4 Suppl) 1249 - 1257.

Flynn, AA; Green, AJ; Pedley, RB; Boxer, GM; Dearling, J; Watson, R; ... Begent, RHJ; + view all (2002) A model-based approach for the optimization of radioimmunotherapy through antibody design and radionuclide selection. In: CANCER. (pp. 1249 - 1257). JOHN WILEY & SONS INC

Flynn, AA; Pedley, RB; Green, AJ; Boxer, GM; Boden, R; Bhatia, J; ... Begent, RHJ; + view all (2002) Antibody and radionuclide characteristics and the enhancement of the effectiveness of radioimmunotherapy by selective dose delivery to radiosensitive areas of tumour. INT J RADIAT BIOL , 78 (5) 407 - 415. 10.1080/09553000110117818.

Forbes, LV; Gale, RE; Pizzey, A; Pouwels, K; Nathwani, A; Linch, DC; (2002) An activating mutation in the transmembrane domain of the granulocyte colony-stimulating factor receptor in patients with acute myeloid leukemia. ONCOGENE , 21 (39) 5981 - 5989. 10.1038/sj.onc.1205767.

Ford, HER; Mitchell, F; Cunningham, D; Farrugia, DC; Hill, ME; Rees, C; ... Jackman, AL; + view all (2002) Patterns of elevation of plasma 2 '-deoxyuridine, a surrogate marker of thymidylate synthase (TS) inhibition, after administration of two different schedules of 5-fluorouracil and the specific TS inhibitors raltitrexed (Tomudex) and ZD9331. CLIN CANCER RES , 8 (1) 103 - 109.

Francis, RJ; Green, AJ; Baig, S; Knell, V; Frisken, I; Bowen, RL; ... Begent, RHJ; + view all (2002) A novel approach to assessing response to chemotherapy using hybrid camera FDG PET. BRIT J CANCER , 86 S100 - S100.

Francis, RJ; Sharma, SK; Springer, C; Green, AJ; Hope-Stone, LD; Sena, L; ... Begent, RHJ; + view all (2002) A phase I trial of antibody directed enzyme prodrug therapy (ADEPT) in patients with advanced colorectal carcinoma or other CEA producing tumours. BRIT J CANCER , 87 (6) 600 - 607. 10.1038/sj.bjc.6600517.

Freeman, A; Treurnicht, K; Munson, P; Miller, K; Parkinson, MC; (2002) A comparison of basal cell markers used in the prostate. HISTOPATHOLOGY , 40 (5) 492 - 494.


Gale, RE; (2002) Basic sciences of the myeloproliferative diseases: Pathogenic mechanisms of ET and PV. INT J HEMATOL , 76 305 - 310.

Ganeshaguru, K; Wickremasinghe, RG; Jones, DT; Gordon, M; Hart, SM; Virchis, AE; ... Mehta, AB; + view all (2002) Actions of the selective protein kinase C inhibitor PKC412 on B-chronic lymphocytic leukemia cells in vitro. Haematologica , 87 (2) 167 - 176. Gold open access

Ganeshaguru, K; Wickremasinghe, RG; Jones, DT; Gordon, M; Hart, SM; Virchis, AE; ... Mehta, AB; + view all (2002) Actions of the selective protein kinase C inhibitor PKC412 on B-chronic lymphocytic leukemia cells in vitro. HAEMATOLOGICA , 87 (2) 167 - 176. Gold open access

Gardiner, C; Cooper, PC; Makris, M; Mackie, IJ; Malia, RG; Machin, SJ; (2002) An evaluation of screening tests for defects in the protein C pathway: commercial kits lack sensitivity and specificity. BLOOD COAGUL FIBRIN , 13 (2) 155 - 163.

Gardiner, C; Mackie, IJ; Furrs, SA; Piegsa, K; Guillebaud, J; Machin, SJ; (2002) Acquired resistance to activated protein C is more pronounced in women receiving combined oral contraceptives containing desogestrel than levonorgestrel and is associated with low protein S levels. In: BLOOD. (pp. 113B - 113B). AMER SOC HEMATOLOGY

Geary, JE; Verfuerth, S; Thomas, AC; Peggs, KS; Mackinnon, S; (2002) Kinetics of lineage-specific chimerism following an alemtuzumab (Campath-1H) reduced intensity regimen and the effect on chimerism of donor leukocyte infusions. In: BLOOD. (pp. 398B - 399B). AMER SOC HEMATOLOGY

Gerrard, G; Ganeshaguru, K; Baker, R; Potter, M; Prentice, HG; Burgess, M; ... Mehta, AB; + view all (2002) Inhibition of P-gp activity in AML patients treated with zosuquidar trihydrochloride (LY335979): In vitro data from a phase 1 trial. In: BLOOD. (pp. 67A - 67A). AMER SOC HEMATOLOGY

Gillespie, SH; Gosling, RD; Charalambous, BM; (2002) A reiterative method for calculating the early bactericidal activity of antituberculosis drugs. AM J RESP CRIT CARE , 166 (1) 31 - 35. 10.1164/rccm.2112077.

Goldring, K; Jones, GE; Poirier, F; Prasad, R; Tavsanoglu, Y; Watt, DJ; (2002) The galectin-1 null mouse furthers the understanding of the role of galectin-1 in muscle formation, differentiation and regeneration. In: NEUROMUSCULAR DISORDERS. (pp. 719 - 720). PERGAMON-ELSEVIER SCIENCE LTD

Goldring, K; Jones, GE; Sewry, CA; Watt, DJ; (2002) The muscle-specific marker desmin is expressed in a proportion of human dermal fibroblasts after their exposure to galectin-1. NEUROMUSCULAR DISORD , 12 (2) 183 - 186.

Goldring, K; Jones, GE; Thiagarajah, R; Watt, DJ; (2002) The effect of galectin-1 on the differentiation of fibroblasts and myoblasts in vitro. J CELL SCI , 115 (2) 355 - 366.

Goldring, K; Partridge, T; Watt, D; (2002) Muscle stem cells. J PATHOL , 197 (4) 457 - 467. 10.1002/path.1157.

Gonzalez, M; Quezada, SA; Blazar, BR; Panoskaltsis-Mortari, A; Rudensky, AY; Noelle, RJ; (2002) The balance between donor T cell anergy and suppression versus lethal graft-versus-host disease is determined by host conditioning. J IMMUNOL , 169 (10) 5581 - 5589.

Gordon, FH; Hamilton, MI; Donoghue, S; Greenlees, C; Palmer, T; Rowley-Jones, D; ... Pounder, RE; + view all (2002) A pilot study of treatment of active ulcerative colitis with natalizumab, a humanized monoclonal antibody to alpha-4 integrin. ALIMENT PHARM THER , 16 (4) 699 - 705.

Gore, M; Oza, A; Rustin, G; Malfetano, J; Calvert, H; Clarke-Pearson, D; ... Fields, SZ; + view all (2002) A randomised trial of oral versus intravenous topotecan in patients with relapsed epithelial ovarian cancer. EUR J CANCER , 38 (1) 57 - 63.

Gower, NH; Rudd, RM; James, LE; Gregory, W; Eisen, T; Lee, SM; ... Spiro, SG; + view all (2002) Gemcitabine and carboplatin (GC) versus mitomycin, ifosfamide and cisplatin (MIP): a phase III randomised comparison in stage IIIb or IV non-small cell lung cancer (NSCLC). In: European Respiratory Journal. (pp. 399 - ?).

Gower, NH; Rudd, RM; James, LE; Gregory, W; Eisen, T; Lee, SM; ... Spiro, SG; + view all (2002) Gemcitabine/carboplatin (GC) versus mitomycin/ifosfamide/cisplatin (MIP): A randomised comparison in patients with advanced non-small cell lung cancer (NSCLC). British Journal of Cancer , 86 S1 - S1.

Grimaldi, KA; McGurk, CJ; McHugh, PJ; Hartley, JA; (2002) PCR-based methods for detecting DNA damage and its repair at the sub-gene and single nucleotide levels in cells. MOL BIOTECHNOL , 20 (2) 181 - 196.

Grimwade, D; Outram, SV; Flora, R; Ings, SJ; Pizzey, AR; Morilla, R; ... Solomon, E; + view all (2002) The T-Lineage-affiliated CD2 gene lies within an open chromatin environment in acute promyelocytic leukemia cells. CANCER RES , 62 (16) 4730 - 4735.

GUPTA, R; Bain, BJ; (2002) Cytogenetic and molecular genetic abnormalities in systemic mastocytosis. Acta Haematol , 107 (2) 123 - 128. 10.1159/000046642.


Hale, G; Slavin, S; Goldman, JM; Mackinnon, S; Giralt, S; Waldmann, H; (2002) Alemtuzumab (Campath-1H) for treatment of lymphoid malignancies in the age of nomnyeloablative conditioning? BONE MARROW TRANSPL , 30 (12) 797 - 804. 10.1038/sj.bmt.1703733.

Hanawa, H; Kelly, PF; Nathwani, AC; Persons, DA; Vandergriff, JA; Hargrove, P; ... Nienhuis, AW; + view all (2002) Comparison of various envelope proteins for their ability to pseudotype lentiviral vectors and transduce primitive hematopoietic cells from human blood. Molecular Therapy , 5 (3) 242 - 251.

Haralambieva, E; Jones, M; Roncador, GM; Cerroni, L; Lamant, L; Ott, G; ... Mason, DY; + view all (2002) Tyrosine phosphorylation in human lymphomas. Histochem J , 34 (11-12) 545 - 552.

Harrison, CN; Donohoe, S; Carr, P; Dave, M; Mackie, I; Machin, SJ; (2002) Patients with essential thrombocythaemia have an increased prevalence of antiphospholipid antibodies which may be associated with thrombosis. THROMB HAEMOSTASIS , 87 (5) 802 - 807.

Harrison, P; Robinson, M; Liesner, R; Khair, K; Cohen, H; Mackie, I; Machin, S; (2002) The PFA-100((R)): a potential rapid screening tool for the assessment of platelet dysfunction. CLIN LAB HAEMATOL , 24 (4) 225 - 232.

Heelan, BT; Tormey, V; Amlot, PL; Payne, E; Mehta, A; Webster, AD; (2002) Effect of anti-CD20 (rituximab) on resistant thrombocytopenia in autoimmune lymphoproliferative syndrome. British Journal of Haematology , 118 (4) 1078 - 1081.

Hercus, B; Saeed, S; Revell, PA; (2002) Expression profile of T cell associated molecules in the interfacial tissue of aseptically loosened prosthetic joints. J Mater Sci Mater Med , 13 (12) 1153 - 1156.

Herrero, J; Dopazo, J; (2002) Combining hierarchical clustering and self-organizing maps for exploratory analysis of gene expression patterns. J Proteome Res , 1 (5) 467 - 470.

Herrero-Martinez, E; Sabin, CA; Evans, JG; Griffioen, A; Lee, CA; Emery, VC; (2002) The prognostic value of a single hepatitis C virus RNA load measurement taken early after human immunodeficiency virus seroconversion. J INFECT DIS , 186 (4) 470 - 476.

Heyworth, C; Pearson, S; May, G; Enver, T; (2002) Transcription factor-mediated lineage switching reveals plasticity in primary committed progenitor cells. EMBO J , 21 (14) 3770 - 3781.

Hoskin, PJ; (2002) FDG PET in the management of lymphoma: a clinical perspective. European Journal of Nuclear Medicine and Molecular Imaging , 29 (4) 449 - 451.

Hoskin, PJ; Bownes, P; Summers, A; (2002) The influence of applicator angle on dosimetry in vaginal vault brachytherapy. British Journal of Radiology , 75 (891) 234 - 237.

Howard, J; Hoffbrand, AV; Prentice, HG; Mehta, A; (2002) Mycophenolate mofetil for the treatment of refractory auto- immune haemolytic anaemia and auto-immune thrombocytopenia purpura. British Journal of Haematology , 117 (3) 712 - 715.

Howard, TT; Lingerfelt, BM; Purnell, BL; Scott, AE; Price, CA; Townes, HM; ... Lee, M; + view all (2002) Novel furano analogues of duocarmycin C1 and C2: Design, synthesis, and biological evaluation of seco-iso-cyclopropylfurano[2,3-e]indoline (seco-iso-CFI) and seco-cyclopropyltetrahydrofurano[2,3-f]quinoline (seco-CFQ) analogues. BIOORGAN MED CHEM , 10 (9) 2941 - 2952.

Hughes, A; Calvert, P; Azzabi, A; Plummer, R; Johnson, R; Rusthoven, J; ... Calvert, H; + view all (2002) Phase I clinical and pharmacokinetic study of pemetrexed and carboplatin in patients with malignant pleural mesothelioma. J CLIN ONCOL , 20 (16) 3533 - 3544. 10.1200/JCO.2002.10.073.

Hughes, SE; (2002) Cardiac stem cells. The Journal of Pathology (197) 468 - 478.

Huntly, BJP; Bench, AJ; Delabesse, E; Reid, AG; Li, J; Scott, MA; ... Green, AR; + view all (2002) Derivative chromosome 9 deletions in chronic myeloid leukemia: poor prognosis is not associated with loss of ABL-BCR expression, elevated BCR-ABL levels, or karyotypic instability. In: BLOOD. (pp. 4547 - 4553). AMER SOC HEMATOLOGY


Imrie, KR; Linch, DC; Czuczman, MS; (2002) Debate on the conservative and aggressive treatment options for the optimal management of indolent non-Hodgkin's lymphoma. ANTI-CANCER DRUGS , 13 S19 - S24.


James, LE; Rudd, RM; Gower, NH; Gregory, W; Lee, SM; Eisen, T; ... Spiro, SG; + view all (2002) A phase III randomised comparison of gemcitabine/carboplatin (GC) with cisplatin/etoposide (PE) in patients with poor prognosis small cell lung cancer (SCLC. In: Proceedings of Association of the American Society of Clinical Oncology. (pp. 1170 - ?).

James, LE; Rudd, RM; Gower, NH; Gregory, W; Lee, SM; Eisen, T; ... Spiro, SG; + view all (2002) A randomised phase III comparison of gemcitabine/carboplatin (GC) with cisplatin/etoposide (PE) in patients with poor prognosis small cell lung cancer (SCLC). In: European Respiratory Journal. (pp. 399 - ?).

Janinis, J; McTiernan, A; Driver, D; Mitchell, C; Cassoni, AM; Pringle, J; ... London Bone and Soft Tissue Tumour,; + view all (2002) A pilot study of short-course intensive multiagent chemotherapy in metastatic and axial skeletal osteosarcoma. ANN ONCOL , 13 (12) 1935 - 1944. 10.1093/annonc/mdf338.

Jennings, BH; (2002) Stopping Transcription in its Tracks. Nature Genetics , 32 87 - 88.

Jennings, I; Greaves, M; Mackie, IJ; Kitchen, S; Woods, TAL; Preston, FE; UK Natl External Quality Assessmen,; (2002) Lupus anticoagulant testing: improvements in performance in a UKNEQAS proficiency testing exercise after dissemination of national guidelines on laboratory methods. BRIT J HAEMATOL , 119 (2) 364 - 369.

Jones, B; Aird, E; Colyer, H; Dobbs, J; Harris, R; Hoskin, P; ... West, C; + view all (2002) United Kingdom Radiation Oncology 1 conference (UKRO 1): Accuracy and uncertainty in radiotherapy. British Journal of Radiology , 75 (892) 297 - 306.

Jones, DT; Ganeshaguru, K; Anderson, RJ; Jackson, TR; Bruckdorfer, KR; Low, SY; ... Wickremasinghe, RG; + view all (2002) Albumin activates the AKT signalling pathway and protects B-chronics lymphocytic leukemia cells from chlorambucil- and radiation-induced apoptosis. Blood 10.1182/blood-2002-07-2143. Green open access

Joshi, CV; Enver, T; (2002) Plasticity revisited. CURR OPIN CELL BIOL , 14 (6) 749 - 755. 10.1016/A0955-0674(02)00392-7.

Judson, I; Leahy, M; Whelan, JS; Lorigan, P; Verrill, M; Grimer, R; Robinson, M; (2002) A guideline for the management of gastrointestinal stromal tumour (GIST). Sarcoma , 6 83 - 87. Gold open access


Kapsa, RM; Quigley, AF; Vadolas, J; Steeper, K; Ioannou, PA; Byrne, E; Kornberg, AJ; (2002) Targeted gene correction in the mdX mouse using short DNA fragments: towards application with bone marrow-derived cells for autologous remodeling of dystrophic muscle. Gene Therapy , 9 (11) 695 - 699.

Kapsa, RMI; Wong, SHA; Bertoncello, I; Quigley, AF; Williams, B; Sells, K; ... Kornberg, AJ; + view all (2002) CD45 fraction bone marrow cells as potential delivery vehicles for genetically corrected dystrophin loci. Neuromuscular Disorders , 12 S61 - S66.

Kayyali, R; Hider, RC; Porter, JB; (2002) Combined chelation using deferiprone with deferoxamine induces synergistic inhibition of non-heme iron enzymes. In: BLOOD. (pp. 445A - 445A). AMER SOC HEMATOLOGY

Kenny, PA; Enver, T; Ashworth, A; (2002) Retroviral vectors for establishing tetracycline-regulated gene expression in an otherwise recalcitrant cell line. BMC MOL BIOL , 3 , Article 13. 10.1186/1471-2199-3-13. Green open access

Kiakos, K; Howard, TT; Lee, M; Hartley, JA; McHugh, PJ; (2002) Saccharomyces cerevisiae RAD5 influences the excision repair of DNA minor groove adducts. J BIOL CHEM , 277 (46) 44576 - 44581. 10.1074/jbc.M208169200. Gold open access

Kichler, A; Chillon, M; Leborgne, C; Danos, O; Frisch, B; (2002) Intranasal gene delivery with a polyethylenimine-PEG conjugate. J Control Release , 81 (3) 379 - 388.

Kirkham, LA; Bateman, AR; Melcher, AA; Vile, RG; Fielding, AK; (2002) Lack of specificity of cell-surface protease targeting of a cytotoxic hyperfusogenic gibbon ape leukaemia virus envelope glycoprotein. J Gene Med , 4 (6) 592 - 600. 10.1002/jgm.306.

Kitajima, K; Masuhara, M; Era, T; Enver, T; Nakano, T; (2002) GATA-2 and GATA-2/ER display opposing activities in the development and differentiation of blood progenitors. EMBO J , 21 (12) 3060 - 3069.

Koch, SSC; Thoresen, LH; Tikhe, JG; Maegley, KA; Almassy, RJ; Li, JK; ... Hostomsky, Z; + view all (2002) Novel tricyclic poly(ADP-ribose) polymerase-1 inhibitors with potent anticancer chemopotentiating activity: Design, synthesis, and X-ray cocrystal structure. J MED CHEM , 45 (23) 4961 - 4974. 10.1021/jm02059n.

Kocjan, G; (2002) Cytopathology of the thyroid. Current Diagnostic Pathology , 8 201 - 205.

Kocjan, G; (2002) Pitfalls in cytology of endocrine organs. CPD Bulletin Cellular Pathology , 4 21 - 29.

Koh, MBC; Cotter, FE; Prentice, HG; Lowdell, MW; (2002) Removal of allo-specific lymphocytes from MHC-mismatched grafts prevents graft-versus-host disease in vivo and retains anti-viral CTL. LEUKEMIA , 16 (3) 411 - 411.

Koh, MBC; Prentice, HG; Corbo, M; Morgan, M; Cotter, FE; Lowdell, MW; (2002) Alloantigen-specific T-cell depletion in a major histocompatibility complex fully mismatched murine model provides effective graft-versus-host disease prophylaxis in the presence of lymphoid engraftment. BRIT J HAEMATOL , 118 (1) 108 - 116.

Kottaridis, PD; Craddock, C; Chopra, R; Milligan, DW; Vandenberghe, E; Parker, A; ... Mackinnon, S; + view all (2002) Reduced intensity allogeneic transpalntation in patients above the age of 50 years. In: BLOOD. (pp. 454B - 454B). AMER SOC HEMATOLOGY

Kottaridis, PD; Gale, RE; Holt, M; Wheatley, K; Goldstone, AH; Burnett, AK; Linch, DC; (2002) Consolidation of AML therapy with autograft and allograft procedures does not negate the poor prognostic impact of FLT3 internal tandem duplications: Results from the UK MRC AML 10 and 12 trials. In: BLOOD. (pp. 75A - 75A). AMER SOC HEMATOLOGY

Kottaridis, PD; Gale, RE; Langabeer, SE; Frew, ME; Bowen, DT; Linch, DC; (2002) Studies of FLT3 mutations in paired presentation and relapse samples from patients with acute myeloid leukemia: implications for the role of FLT3 mutations in leukemogenesis, minimal residual disease detection, and possible therapy with FLT3 inhibitors. BLOOD , 100 (7) 2393 - 2398. 10.1182/blood-2002-02-0420.

Kottaridis, PD; Peggs, K; Schmitz, N; Dreger, P; Boogaerts, MA; Ferrant, A; ... Goldstone, AH; + view all (2002) Survival and freedom from progression in autotransplant lymphoma patients is independent of stem cell source: Further follow-up from the original randomised study to assess engraftment. LEUKEMIA LYMPHOMA , 43 (3) 531 - 536. 10.1080/10428190290012010.

Kottke, TJ; Blajeski, AL; Meng, XW; Svingen, PA; Ruchaud, S; Mesner, PW; ... Kaufmann, SH; + view all (2002) Lack of correlation between caspase activation and caspase activity assays in paclitaxel-treated MCF-7 breast cancer cells. 804 - 815. Gold open access

Kralovicova, J; Marsh, SGE; Waller, MJ; Hammarstrom, L; Vorechovsky, I; (2002) The HLA-DRA*0102 allele: Correct nucleotide sequence and associated HLA haplotypes. Tissue Antigens , 60 (3) 266 - 267.

Kularatne, BY; Lorigan, P; Browne, S; Suvarna, SK; Smith, NO; Lawry, J; (2002) Monitoring tumour cells in the peripheral blood of small cell lung cancer patients. CYTOMETRY , 50 (3) 160 - 167. 10.1002/cyto.10071.

Kumar, S; Chandra, J; Grote, D; Cattaneo, R; Kaufmann, S; Fielding, A; (2002) Bcl-2 over-expression results in decreased measles virus mediated cytotoxicity in lymphoma cell lines. In: BLOOD. (pp. 577A - 578A).

Kyriacou, CA; Goldstone, AH; Taghipour, G; Avivi, I; Kottaridis, PD; Dogan, A; ... Schmitz, N; + view all (2002) Patients with chemosensitive angioimmunoblastic lymphoma (AITL) can be salvaged with autologous stem cell transplantation, irrespectively of the number of previous treatment lines. Analysis of 74 cases from the European Bone Marrow Transplant Registry (EBMT). In: BLOOD. (pp. 644A - 644A). AMER SOC HEMATOLOGY


Lagging, LM; Garcia, CE; Westin, J; Wejstal, R; Norkrans, G; Dhillon, AP; Lindh, M; (2002) Comparison of serum hepatitis C virus RNA and core antigen concentrations and determination of whether levels are associated with liver histology or affected by specimen storage time. J CLIN MICROBIOL , 40 (11) 4224 - 4229. 10.1128/JCM.40.11.4224-4229.2002.

Lagging, LM; Westin, J; Svensson, E; Aires, N; Dhillon, AP; Lindh, M; ... Norkrans, G; + view all (2002) Progression of fibrosis in untreated patients with hepatitis C virus infection. LIVER , 22 (2) 136 - 144.

Langabeer, SE; Gale, RE; Harvey, RC; Cook, RW; Mackinnon, S; Linch, DC; (2002) Transcription-mediated amplification and hybridisation protection assay to determine BCR-ABL transcript levels in patients with chronic myeloid leukaemia. Leukemia , 16 (3) 393 - 399. 10.1038/sj/leu/2402392.

Langabeer, SE; Gale, RE; Harvey, RC; Cook, RW; Mackinnon, S; Linch, DC; (2002) Transcription-mediated amplification and hybridisation protection assay to determine BCR-ABL transcript levels in patients with chronic myeloid leukaemia. Leukemia , 16 (3) 393 - 399. 10.1038/sj.leu.2402392.

Langabeer, SE; Gale, RE; Harvey, RC; Cook, RW; Mackinnon, S; Linch, DC; (2002) Transcription-mediated amplification and hybridisation protection assay to determine BCR-ABL transript levels in patients with chronic myeloid leukaemia. LEUKEMIA , 16 (3) 393 - 399. 10.1038/sj/leu/2402392.

Langabeer, SE; Gale, RE; Linch, DC; Rollinson, SJ; Morgan, GJ; (2002) Mutations of the AMLI gene in acute myeloid leukemia of FAB types M0 and M7. Genes Chromosomes and Cancer , 34 (1) 24 - 32. 10.1002/gcc.10031.

Langabeer, SE; Gale, RE; Rollinson, SJ; Morgan, GJ; Linch, DC; (2002) Mutations of the AML1 gene in acute myeloid leukemia of FAB types M0 and M7. GENE CHROMOSOME CANC , 34 (1) 24 - 32. 10.1002/gcc.10031.

Ledermann, JA; Herd, R; (2002) High-Dose Chemotherapy in Ovarian Cancer in High Dose Chemotherapy:. In: Lorrigan, P and Vandenberghe, E, (eds.) Principles and Practice. (143 - 156). Martin Dunitz

Lee, YC; Boehm, MK; Chester, KA; Begent, RHJ; Perkins, SJ; (2002) Reversible dimer formation and stability of the anti-tumour single-chain Fv antibody MFE-23 by neutron scattering, analytical ultracentrifugation, and NMR and FT-IR spectroscopy. J MOL BIOL , 320 (1) 107 - 127. 10.1016/S0022-2836(02)00403-5.

Leonard, P; Ledermann, JA; (2002) Gastrointestinal Oncology in Practical Gastroenterology. In: Bloom, S, (ed.) Practical Gastroenterology. (225 - 240). Martin Dunitz

Leonard, P; Seymour, MT; James, R; Hochhauser, D; Ledermann, JA; (2002) Phase II study of irinotecan with bolus and high dose infusional 5-FU and folinic acid (modified de Gramont) for first or second line treatment of advanced or metastatic colorectal cancer. BRIT J CANCER , 87 (11) 1216 - 1220. 10.1038/sj.bjc.6606641.

Leonard, P; Seymour, MT; James, R; Hochhauser, D; Ledermann, JA; (2002) Phase II study of irinotecan with bolus and high dose infusional 5-FU and folinic acid (modified de Gramont) for first or second line treatment of advanced or metastatic colorectal cancer. Br J Cancer , 87 (11) 1216 - 1220. 10.1038/sj.bjc.6600641.

Leśnikowski, ZJ; Paradowska, E; Przepiórkiewicz, M; Olejniczak, A; Emery, VC; (2002) [Drugs against human cytomegalovirus]. Pol Merkur Lekarski , 13 (75) 242 - 249.

Linch, DC; Yung, L; Smith, P; Maclennan, K; Jack, A; Hancock, B; ... UK Lymphoma Grp,; + view all (2002) A randomised trial of CHOP x 6-8 vs CHOP x 3+BEAM + ASCT in 457 patients with poor prognosis histologically aggressive non-Hodgkins lymphoma. BRIT J CANCER , 86 S1 - S2.

Liu, HX; Huang, XB; Zhang, Y; Ye, HT; El Hamidi, A; Kocjan, G; ... Du, MQ; + view all (2002) Archival fixed histologic and cytologic specimens including stained and unstained materials are amenable to RT-PCR. DIAGN MOL PATHOL , 11 (4) 222 - 227.

Liu, Y; Dodds, P; Emilion, G; Mungall, AJ; Dunham, I; Beck, S; ... Ganesan, TS; + view all (2002) The human homologue of unc-93 maps to chromosome 6q27 - characterisation and analysis in sporadic epithelial ovarian cancer. BMC Genetics , 3 , Article 20. 10.1186/1471-2156-3-20. Green open access

Liu, Y; Emilion, G; Mungall, AJ; Dunham, I; Beck, S; Le Meuth-Metzinger, VG; ... Ganesan, TS; + view all (2002) Physical and transcript map of the region between D6S264 and D6S149 on chromosome 6q27, the minimal region of allele loss in sporadic epithelial ovarian cancer. ONCOGENE , 21 (3) 387 - 399.

Liu, ZD; Kayyali, R; Hider, RC; Porter, JB; Theobald, AE; (2002) Design, synthesis, and evaluation of novel 2-substituted 3-hydroxypyridin-4-ones: Structure-activity investigation of metalloenzyme inhibition by iron chelators. J MED CHEM , 45 (3) 631 - 639. 10.1021/jm010817i.

Lock, MJ; Thorley, N; Teo, J; Emery, VC; (2002) Azidodeoxythymidine and didehydrodeoxythymidine as inhibitors and substrates of the human herpesvirus 8 thymidine kinase. J ANTIMICROB CHEMOTH , 49 (2) 359 - 366.

Lomas, DA; (2002) Chronic obstructive pulmonary disease. Introduction. Thorax , 57 (8) 735 - ?.

Lomas, DA; Carrell, RW; (2002) Serpinopathies and the conformational dementias. Nat Rev Genet , 3 (10) 759 - 768. 10.1038/nrg907.

Lomas, DA; Lourbakos, A; Cumming, SA; Belorgey, D; (2002) Hypersensitive mousetraps, alpha1-antitrypsin deficiency and dementia. Biochem Soc Trans , 30 (2) 89 - 92.

Lomas, DA; Mahadeva, R; (2002) alpha(1)-Antitrypsin polymerization and the serpinopathies: pathobiology and prospects for therapy. JOURNAL OF CLINICAL INVESTIGATION , 110 (11) 1585 - 1590. 10.1172/JCI200216782.

Lomas, DA; Mahadeva, R; (2002) Alpha1-antitrypsin polymerization and the serpinopathies: pathobiology and prospects for therapy. J Clin Invest , 110 (11) 1585 - 1590. 10.1172/JCI16782.

Lowdell, MW; Craston, R; Samuel, D; Wood, ME; O'Neill, E; Saha, V; Prentice, HG; (2002) Evidence that continued remission in patients treated for acute leukaemia is dependent upon autologous natural killer cells. BRIT J HAEMATOL , 117 (4) 821 - 827.


Mackinnon, S; (2002) Alemtuzumab and reduced intensity conditioning. BLOOD , 100 (4) 1508 - 1509.

Mackinnon, S; Peggs, K; Verfuerth, S; Pizzey, A; Ainsworth, J; Moss, P; (2002) Characterization of human cytomegalovirus peptide-specific CD8 T-cell repertoire diversity following in vitro restimulation by antigen-pulsed dendritic cells. Blood , 99 (1) 213 - 223. 10.1182/blood.V99.1.213. Green open access

Madsen, E; Summerville, K; Price, C; Toth, J; Hudson, S; Kiakos, K; ... Lee, M; + view all (2002) Molecular recognition of DNA sequence-specific alkylation by conjugates of hairpin polyamide-duocarmycin analogs. ABSTR PAP AM CHEM S , 223 A106 - A106.

Mahadeva, R; Dafforn, TR; Carrell, RW; Lomas, DA; (2002) 6-mer peptide selectively anneals to a pathogenic serpin conformation and blocks polymerization. Implications for the prevention of Z alpha(1)-antitrypsin-related cirrhosis. J Biol Chem , 277 (9) 6771 - 6774. 10.1074/jbc.C100722200. Gold open access

Manderson, EN; Presneau, N; Provencher, D; Mes-Masson, AM; Tonin, PN; (2002) Comparative analysis of loss of heterozygosity of specific chromosome 3, 13, 17, and X loci and TP53 mutations in human epithelial ovarian cancer. MOL CARCINOGEN , 34 (2) 78 - 90. 10.1002/mc.10051.

Marsh, SGE; Albert, ED; Bodmer, WF; Bontrop, RE; Dupont, B; Erlich, HA; ... Terasaki, PI; + view all (2002) Nomenclature for factors of the HLA system, 2002. Human Immunology , 63 (12) 1213 - 1268.

Marsh, SGE; Albert, ED; Bodmer, WF; Bontrop, RE; Dupont, B; Erlich, HA; ... Terasaki, PI; + view all (2002) Nomenclature for factors of the HLA system, 2002. European Journal of Immunogenetics , 29 (6) 463 - 516.

Marsh, SGE; Albert E D, B; W F, B; R E, D; B, E; H A, G; ... P, I; + view all (2002) Nomenclature for factors of the HLA system, 2002. Tissue Antigens , 60 407 - 464.

Mateos, A; Herrero, J; Dopazo, J; (2002) Using perceptrons for supervised classification of DNA microarray samples: Obtaining the optimal level of information and finding differentially expressed genes. In: ARTIFICIAL NEURAL NETWORKS - ICANN 2002. (pp. 577 - 582).

Maughan, TS; James, RD; Kerr, DJ; Ledermann, JA; McArdle, C; Seymour, MT; ... British MRC Colorectal Canc Work,; + view all (2002) Comparison of survival, palliation, and quality of life with three chemotherapy regimens in metastatic colorectal cancer: a multicentre randomised trial. LANCET , 359 (9317) 1555 - 1563.

McKelvie, PA; Collins, S; Thyagarajan, D; Trost, N; Sheorey, H; Byrne, E; (2002) Meningoencephalomyelitis with vasculitis due to varicella zoster virus : a case report and review of the literature. Pathology , 34 (1) 88 - 93.

Mehta, A; (2002) Agalsidase alfa: specific treatment for Fabry disease. Hospital Medicine , 63 (6) 347 - 350.

Mezzina, M; Danos, O; (2002) Five years of vector service for gene therapy. Trends Genet , 18 (3) 118 - 119.

Migliorini, D; Danovi, D; Colombo, E; Carbone, R; Pelicci, PG; Marine, JC; (2002) Hdmx recruitment into the nucleus by Hdm2 is essential for its ability to regulate p53 stability and transactivation. J BIOL CHEM , 277 (9) 7318 - 7323. 10.1074/jbc.M108795200. Gold open access

Migliorini, D; Denchi, EL; Danovi, D; Jochemsen, A; Capillo, M; Gobbi, A; ... Marine, JC; + view all (2002) Mdm4 (Mdmx) regulates p53-induced growth arrest and neuronal cell death during early embryonic mouse development. MOL CELL BIOL , 22 (15) 5527 - 5538. 10.1128/MCB.22.15.5527-5538.2002.

Mills, KI; Gilkes, AF; Linch, DC; Burnett, AK; (2002) Risk group stratification in AML by the use of micro-arrays. In: BLOOD. (pp. 744A - 744A). AMER SOC HEMATOLOGY

Monastiri, K; Ben Ahmed, S; Presneau, N; Bignon, JY; Chouchane, L; (2002) [Rapid detection of BRCA-1 germline mutations by the protein truncation test in Tunisian families]. Tunis Med , 80 (9) 515 - 518.

Morris, E; Thomson, K; Craddock, C; Milligan, D; Smith, GM; Parker, A; ... Mackinnon, S; + view all (2002) Long-term follow-up of an alemtuzumab (CAMPATH-1H) containing reduced intensity allogeneic transplant regimen for non-Hodgkin's lymphoma (NHL). In: BLOOD. (pp. 40A - 40A). AMER SOC HEMATOLOGY

Mushipe, MT; Revell, PA; Shelton, JC; (2002) Cancellous bone repair using bovine trabecular bone matrix particulates. Biomaterials , 23 (2) 365 - 370. 10.1016/S0142-9612(01)00114-4.


Nacheva, EP; Reid, AG; Tarpey, PS; Grace, CD; (2002) Quantification of locus copy number in chronic myeloid leukaemia using multiplex amplifiable probe hybridisation (MAPH). In: BLOOD. (pp. 325B - 325B). AMER SOC HEMATOLOGY

Nakahara, T; Yaguchi, H; Yoshida, M; Miyakoshi, J; (2002) Effects of exposure of CHO-K1 cells to a 10-T static magnetic field. Radiology , 224 (3) 817 - 822. 10.1148/radiol.2243011300.

Nathwani, A; Davidoff, AM; Hanawa, H; Hu, Y; Hoffer, FA; Nikanorov, A; ... Nienhuis, AW; + view all (2002) Sustained high-level expression of human factor IX (hFIX) after liver-targeted delivery of recombinant adeno-associated virus encoding the hFIX gene in rhesus macaques. Blood , 100 (5) 1662 - 1669. 10.1182/blood-2002-02-0589. Green open access

Nehls, O; Klump, B; Arkenau, HT; Hass, HG; Greschniok, A; Gregor, M; Porschen, R; (2002) Oxaliplatin, fluorouracil and leucovorin for advanced biliary system adenocarcinomas: a prospective phase II trial. Br J Cancer , 87 (7) 702 - 704. 10.1038/sj.bjc.6600543.

Nicholson, PW; Harland, SJ; (2002) Survival prospects after screen-detection of prostate cancer. BJU INT , 90 (7) 686 - 693. 10.1046/j.1464-4096.2002.03005.x.

Nikitenko, LL; Smith, DM; Hague, S; Wilson, CR; Bicknell, R; Rees, MCP; (2002) Adrenomedullin and the microvasculature. TRENDS PHARMACOL SCI , 23 (3) 101 - 103.

Niyikiza, C; Baker, SD; Seitz, DE; Walling, JM; Nelson, K; Rusthoven, JJ; ... Allen, RH; + view all (2002) Homocysteine and methylmalonic acid: Markers to predict and avoid toxicity from pemetrexed therapy. MOL CANCER THER , 1 (7) 545 - 552.

Niyikiza, C; Hanauske, AR; Rusthoven, JJ; Calvert, AH; Allen, R; Paoletti, P; Bunn, PA; (2002) Pemetrexed safety and dosing strategy. SEMIN ONCOL , 29 (6) 24 - 29. 10.1053/sonc.2002.37465.

Novik, KL; Nimmrich, I; Genc, B; Maier, S; Piepenbrock, C; Olek, A; Beck, S; (2002) Epigenomics: genome-wide study of methylation phenomena. Curr Issues Mol Biol , 4 (4) 111 - 128. Gold open access


O'Hare, CC; Mack, D; Tandon, M; Sharma, SK; Lown, JW; Kopka, ML; ... Hartley, JA; + view all (2002) DNA sequence recognition in the minor groove by crosslinked polyamides: The effect of N-terminal head group and linker length on binding affinity and specificity. P NATL ACAD SCI USA , 99 (1) 72 - 77.

Oakley, TJ; Goodwin, A; Chakraverty, RK; Hickson, ID; (2002) Inactivation of homologous recombination suppresses defects in topoisomerase III-deficient mutants. DNA Repair (Amst) , 1 (6) 463 - 482.

Ohkura, N; Yaguchi, H; Tsukada, T; Yamaguchi, K; (2002) The EWS/NOR1 fusion gene product gains a novel activity affecting pre-mRNA splicing. J Biol Chem , 277 (1) 535 - 543. 10.1074/jbc.M109018200. Gold open access

Okkenhaug, K; Bilancio, A; Farjot, G; Priddle, H; Sancho, S; Peskett, E; ... Vanhaesebroeck, B; + view all (2002) Impaired B and T cell antigen receptor signaling in p110delta PI 3-kinase mutant mice. Science , 297 (5583) 1031 - 1034. 10.1126/science.1073560.


Parmar, JS; Mahadeva, R; Reed, BJ; Farahi, N; Cadwallader, KA; Keogan, MT; ... Lomas, DA; + view all (2002) Polymers of alpha(1)-antitrypsin are chemotactic for human neutrophils: a new paradigm for the pathogenesis of emphysema. Am J Respir Cell Mol Biol , 26 (6) 723 - 730. 10.1165/ajrcmb.26.6.4739.

Parmar, MKB; Adams, M; Balestrino, M; Bertelsen, K; Bonazzi, C; Calvert, H; ... ICON Grp,; + view all (2002) Paclitaxel plus carboplatin versus standard chemotherapy with either single-agent carboplatin or cyclophosphamide, doxorubicin, and cisplatin in women with ovarian cancer: the ICON3 randomised trial. LANCET , 360 (9332) 505 - 515.

Parsons, MJ; Pollard, SM; Saúde, L; Feldman, B; Coutinho, P; Hirst, EM; Stemple, DL; (2002) Zebrafish mutants identify an essential role for laminins in notochord formation. Development , 129 (13) 3137 - 3146.

Patel, BD; Tasker, A; Screaton, N; Anderson, W; Sharma, S; Silverman, EK; Lomas, DA; (2002) Smoking related emphysema and small airways disease have independent genetic risk factors in COPD. In: THORAX.

Patel, Y; Moraes, YC; Latchman, D; Coffin, R; de Belleroche, J; (2002) Neuroprotective effects of copper/zinc-dependent superoxide dismutase against a wide variety of death-inducing stimuli and proapoptotic effect of familial amyotrophic lateral sclerosis mutations. MOL BRAIN RES , 109 (1-2) 189 - 197.

Paul, MJ; Summers, Y; Calvert, AH; Rustin, G; Brampton, MH; Thatcher, N; Middleton, MR; (2002) Effect of temozolomide on central nervous system relapse in patients with advanced melanoma. MELANOMA RES , 12 (2) 175 - 178.

Payne, EM; Gerrard, G; Ganeshaguru, K; McCullough, H; Ethell, M; Potter, M; ... Mehta, AB; + view all (2002) A phase 1 study of the P-glycoprotein inhibitor zosuquidar trihydrochloride (LY335979) in combination with daunorubicin and cytarabine in adult acute myeloid leukemia. BLOOD , 100 (11) 557A - 557A.

Pedley, RB; El-Emir, E; Flynn, AA; Boxer, GM; Dearling, J; Raleigh, JA; ... Begent, RHJ; + view all (2002) Synergy between vascular targeting agents and antibody-directed therapy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , 54 (5) 1524 - 1531.

Peggs, K; (2002) Donor lymphocyte infusion following reduced intensity allografting. In: BONE MARROW TRANSPLANTATION. (pp. S37 - S38). NATURE PUBLISHING GROUP

Peggs, K; Verfuerth, S; Pizzey, A; Ainsworth, J; Moss, P; Mackinnon, S; (2002) Characterization of human cytomegalovirus peptide-specific CD8(+) T-cell repertoire diversity following in vitro restimulation by antigen-pulsed dendritic cells. BLOOD , 99 (1) 213 - 223.

Peggs, KS; Mackinnon, S; (2002) Adoptive cellular therapy: a therapeutic reality? Hematology , 7 (3) 127 - 136. 10.1080/1024533021000013915.

Peggs, KS; Mackinnon, S; (2002) Clinical trials with CMV-specific T cells. CYTOTHERAPY , 4 (1) 21 - 28.

Peggs, KS; Mackinnon, S; Yong, K; (2002) Reduced intensity conditioning and allogeneic stem-cell transplantation: Determining its role in multiple myeloma. J CLIN ONCOL , 20 (20) 4268 - 4268.

Peggs, KS; Morris, EC; Kottaridis, PD; Geary, J; Goldstone, AH; Linch, DC; Mackinnon, S; (2002) Outcome of major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation may be influenced by conditioning regimen. BLOOD , 99 (12) 4642 - 4643.

Peggs, KS; Paneesha, S; Kottaridis, PD; Chakraverty, RK; Tobias, G; Reilly, M; ... Yong, K; + view all (2002) Peripheral blood stem cell transplantation for POEMS syndrome. BONE MARROW TRANSPL , 30 (6) 401 - 404. 10.1038/sj.bmt.1703670.

Peltékian, E; Garcia, L; Danos, O; (2002) Neurotropism and retrograde axonal transport of a canine adenoviral vector: a tool for targeting key structures undergoing neurodegenerative processes. Mol Ther , 5 (1) 25 - 32. 10.1006/mthe.2001.0517.

Perera, D; Pizzey, A; Campbell, A; Katz, M; Porter, J; Petrou, M; ... Chatterjee, R; + view all (2002) Sperm DNA damage in potentially fertile homozygous beta-thalassaemia patients with iron overload. HUM REPROD , 17 (7) 1820 - 1825.

Perez, N; Plence, P; Millet, V; Greuet, D; Minot, C; Noel, D; ... Apparailly, F; + view all (2002) Tetracycline transcriptional silencer tightly controls transgene expression after in vivo intramuscular electrotransfer: application to interleukin 10 therapy in experimental arthritis. Hum Gene Ther , 13 (18) 2161 - 2172. 10.1089/104303402320987851.

Perez-Rodriguez, M; Arguello, JR; Fischer, G; Corell, A; Cox, ST; Robinson, J; ... Madrigal, JA; + view all (2002) Further polymorphism of the MICA gene. European Journal of Immunogenetics , 29 (1) 35 - 46.

Perez-Simon, JA; Kottaridis, PD; Martino, R; Craddock, C; Caballero, D; Chopra, R; ... Spanish United Kingdom Collaborat,; + view all (2002) Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders. BLOOD , 100 (9) 3121 - 3127. 10.1182/blood-2002-03-0701.

Peters, GJ; Backus, HHJ; Freemantle, S; van Triest, B; Codacci-Pisanelli, G; van der Wilt, CL; ... Pinedo, HM; + view all (2002) Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE , 1587 (2-3) 194 - 205.

Petrie, IA; Flynn, AA; Pedley, RB; Green, AJ; El-Emir, E; Dearling, JLJ; ... Begent, RHJ; + view all (2002) Spatial accuracy of 3D reconstructed radioluminographs of serial tissue sections and resultant absorbed dose estimates. PHYS MED BIOL , 47 (20) 3651 - 3661.

Pietersen, AAM; Tolboom, TCA; Zhang, YH; van Dijk, L; Henriquez, NV; Noteborn, MHM; Huizinga, TWJ; (2002) Fibroblast-like synoviocytes from RA patients exploit a tumor-specific apoptosis pathway whereas synoviocytes from controls do not. In: ARTHRITIS AND RHEUMATISM. (pp. S137 - S137). WILEY-LISS

Pileri, SA; Ascani, S; Zinzani, PL; Gaidano, G; Piccioli, M; Rossi, M; ... Sabattini, E; + view all (2002) Diffuse large B-cell lymphoma (DLBCL), anaplastic variant. report on a problematic case primarily arising in the stomach. Haematologica , 87 (12) ECR40 - ?. Gold open access

Pileri, SA; Dirnhofer, S; Went, P; Ascani, S; Sabattini, E; Marafioti, T; ... Zinzani, PL; + view all (2002) Diffuse large B-cell lymphoma: one or more entities? Present controversies and possible tools for its subclassification. Histopathology , 41 (6) 482 - 509.

Pileri, SA; Grogan, TM; Harris, NL; Banks, P; Campo, E; Chan, JKC; ... Weiss, LM; + view all (2002) Tumours of histiocytes and accessory dendritic cells: An immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. Histopathology , 41 (1) 1 - 29. 10.1046/j.1365-2559.2002.01418.x.

Platt, G; Carbone, A; Mittnacht, S; (2002) p16INK4a loss and sensitivity in KSHV associated primary effusion lymphoma. Oncogene , 21 (12) 1823 - 1831. 10.1038/sj.onc.1205360.

Plemper, RK; Hammond, AL; Gerlier, D; Fielding, AK; Cattaneo, R; (2002) Strength of envelope protein interaction modulates cytopathicity of measles virus. J Virol , 76 (10) 5051 - 5061.

Plummer, R; Ghielmini, M; Calvert, P; Voi, M; Renard, J; Gallant, G; ... Sessa, C; + view all (2002) Phase I and pharmacokinetic study of the new taxane analog BMS-184476 given weekly in patients with advanced malignancies. CLIN CANCER RES , 8 (9) 2788 - 2797.

Porter, JB; Davis, BA; (2002) Monitoring chelation therapy to achieve optimal outcome in the treatment of thalassaemia. BEST PRACT RES CL HA , 15 (2) 329 - 368. 10.1053/beha.2002.0214.

Pule, M; Gullmann, C; Dennis, D; McMahon, C; Jeffers, M; Smith, OP; (2002) Increased angiogenesis in bone marrow of children with acute lymphoblastic leukaemia has no prognostic significance. British Journal of Haematology , 118 (4) 991 - 998.

Purnell, B; Howard, T; Lingerfelt, B; McNulty, L; Handl, H; Summerville, K; ... Bowen, P; + view all (2002) Novel seco-iso-CFI and seco-CFQ analogs of the duocarmycins: Design, synthesis and biological evaluation. ABSTR PAP AM CHEM S , 223 B133 - B133.

Purnell, B; Lingerfelt, B; Scott, A; Summerville, K; Hudson, S; Kiakos, K; ... Lee, M; + view all (2002) Novel (S)-(+)- and (R)-(-)-seco-iso-CFI analogs of duocarmycin C2. ABSTR PAP AM CHEM S , 223 B133 - B133.


Quaglia, A; Laurent, C; Girlando, S; Saini, J; Dalla Palma, P; Colombari, R; ... Dhillon, AP; + view all (2002) Clonality and genomic heterogeneity in HCC and putative precursor nodular lesions. J HEPATOL , 36 83 - 83.

Quarmby, JW; Engelke, C; Chitolie, A; Morgan, RA; Belli, AM; (2002) Autologous thrombin for treatment of pseudoaneurysms. LANCET , 359 (9310) 946 - 947.


Radosavljevic, M; Cuillerier, B; Wilson, MJ; Clement, O; Wicker, S; Gilfillan, S; ... Bahram, S; + view all (2002) A cluster of ten novel MHC class I related genes on human chromosome 6q24.2-q25.3. GENOMICS , 79 (1) 114 - 123. 10.1006/geno.2001.6673.

Ravichandran, D; Shenoy, V; Kocjan, G; Ball, RY; Ralphs, DNL; (2002) Touch imprint cytology in the assessment of sentinel lymph node status. EUR J CANCER , 38 S61 - S61.

Reid, AG; Huntly, BJP; Hennig, E; Niederwieser, D; Campbell, LJ; Bown, N; ... Nacheva, EP; + view all (2002) Deletions of the derivative chromosome 9 do not account for the poor prognosis associated with Philadelphia-positive acute lymphoblastic leukemia. In: BLOOD. (pp. 2274 - 2275). AMER SOC HEMATOLOGY

Robinson, SP; Sureda, A; Mackinnon, S; Carella, A; Taghipour, G; Goldstone, AH; ... Lymphoma Working Party EBMT,; + view all (2002) Reduced intensity allogeneic stem cell transplantation for Hodgkin's disease: An analysis from the European group for Blood and Marrow Transplantation. In: BLOOD. (pp. 144A - 144A). AMER SOC HEMATOLOGY

Rosti, G; Ferrante, P; Ledermann, J; Leyvraz, S; Ladenstein, R; Koscileniak, E; ... Marangolo, M; + view all (2002) High-dose chemotherapy for solid tumors: results of the EBMT. Crit Rev Oncol Hematol , 41 (2) 129 - 140.

Rudd, RM; Gower, NH; James, LE; Gregory, W; Eisen, T; Lee, SM; ... Spiro, SG; + view all (2002) Phase III randomised comparison of gemcitabine and carboplatin (GC) with mitomycin, ifosfamide and cisplatin (MIP) in advanced non-small cell lung cancer (NSCLC). In: Proceedings of Association of the American Society of Clinical Oncology. (pp. 1164 - ?).

Rudnicka, AR; Wald, NJ; Huttly, W; Hackshaw, AK; (2002) Influence of maternal smoking on the birth prevalence of Down syndrome and on second trimester screening performance. PRENATAL DIAG , 22 (10) 893 - 897. 10.1002/pd.440.


Sabin, CA; Griffioen, A; Yee, TT; Emery, VC; Herrero-Martinez, E; Phillips, AN; Lee, CA; (2002) Markers of HIV-1 disease progression in individuals with haemophilia coinfected with hepatitis C virus: a longitudinal study. LANCET , 360 (9345) 1546 - 1551.

Salomoni, P; Bernardi, R; Changuo, A; Tuttle, S; Pandolfi, PP; (2002) Nuclear dynamics of PML for c-Jun transcriptional regulation in response to DNA damage. In: BLOOD. (pp. 191A - 191A). AMER SOC HEMATOLOGY

Salomoni, P; Pandolfi, PP; (2002) p53 de-ubiquitination: at the edge between life and death. NAT CELL BIOL , 4 (6) E152 - E153. 10.1038/ncb0602-e152.

Salomoni, P; Pandolfi, PP; (2002) The role of PML in tumor suppression. CELL , 108 (2) 165 - 170.

Saunders, MI; Rojas, A; Lyn, BE; Wilson, E; Phillips, H; (2002) Dose-escalation with CHARTWEL (continuous hyperfractionated accelerated radiotherapy week-end less) combined with neo-adjuvant chemotherapy in the treatment of locally advanced non-small cell lung cancer. Clinical Oncology , 14 (5) 352 - 360. 10.1053/clon.2002.0121.

Schellens, JHM; Heinrich, B; Lehnert, M; Gore, ME; Kaye, SB; Dombernowsky, P; ... Hanauske, AR; + view all (2002) Population pharmacokinetic and dynamic analysis of the topoisomerase I inhibitor lurtotecan in phase II studies. INVEST NEW DRUG , 20 (1) 83 - 93.

Scheuer, PJ; Standish, RA; Dhillon, AP; (2002) Scoring of chronic hepatitis. Clin Liver Dis , 6 (2) 335 - vi.

Serra, J; Sales, M; Chitolie, A; Domenech, P; Rossi, E; Borrell, M; Dahlback, B; (2002) Multicentre evaluation of IL Test (TM) Free PS: A fully automated assay to quantify Free Protein S. THROMB HAEMOSTASIS , 88 (6) 975 - 983.

Shah, FT; Westwood, MA; Evans, PJ; Porter, JB; (2002) Discordance in MRI assessment of iron distribution and plasma NTBI between transfusionally iron loaded adults with sickle cell and thalassaemia. In: BLOOD. (pp. 668A - 668A). AMER SOC HEMATOLOGY

Shaw, B; Mehta, AB; (2002) Pancytopenia responding to treatment of hyperthyroidism: A clinical case and review of the literature. Clinical and Laboratory Haematology , 24 (6) 385 - 387. 10.1046/j.1365-2257.2002.00460.x.

Shaw, BE; Marsh, SGE; Mayor, NP; Prentice, HG; Pay, AL; Little, AM; ... Madrigal, JA; + view all (2002) Donor age is not a significant factor affecting overall survival in HLA matched unrelated donor stem cell transplants. TISSUE ANTIGENS , 59 90 - 91.

Shaw, BE; Pay, AL; Potter, MN; Mayor, N; Prentice, HG; Little, AM; ... Madrigal, JA; + view all (2002) HLA-DPB1 plays a role in the outcome of unrelated stem cell transplants in pairs completely matched at the other five transplantation loci. BONE MARROW TRANSPL , 29 S25 - S25.

Shaw, BE; Pay, AL; Potter, MN; Prentice, HG; Mayor, N; Marsh, SGE; Madrigal, JA; (2002) The presence of mild acute graft versus host disease in a T cell depleted unrelated donor transplant setting improves overall survival. BONE MARROW TRANSPL , 29 S39 - S39.

Shaw, BE; Pay, AL; Potter, MN; Travers, P; Mayor, N; Prentice, HG; ... Madrigal, JA; + view all (2002) The importance of patient and donor CMV status in unrelated stem cell transplantation. BONE MARROW TRANSPL , 29 S126 - S126.

Shaw, BE; Potter, MN; Prentice, HG; Mayor, NP; Pay, AL; Marsh, SGE; Madrigal, JA; (2002) Mild acute graft versus host disease improves overall survival in well matched T cell depleted unrelated donor transplants. TISSUE ANTIGENS , 59 124 - 124.

Shaw, BE; Potter, MN; Prentice, HG; Mayor, NP; Pay, AL; Travers, P; ... Madrigal, JA; + view all (2002) Factors implicated in disease relapse following volunteer donor unrelated stem cell transplantation. TISSUE ANTIGENS , 59 125 - 125.

Shing, DC; Morley-Jacob, CA; Roberts, I; Nacheva, E; Coleman, N; (2002) Ewing's tumour: novel recurrent chromosomal abnormalities demonstrated by molecular cytogenetic analysis of seven cell lines and one primary culture. In: Cytogenet Genome Res. (pp. 20 - 27).

Short, KA; GROVES, RW; Novelli, MR; (2002) Haemorrhage into chronic plaque psoriasis as a consequence of disseminated intravascular coagulation. Clinical and Experimental Dermatology , 27 (6) 471 - 473.

Sibtain, A; Hill, S; Goodchild, K; Shah, N; Saunders, M; Hoskin, PJ; (2002) The modification of human tumour blood flow using pentoxifylline, nicotinamide and carbogen. Radiotherapy And Oncology , 62 (1) 69 - 76.

Sierens, J; Hartley, JA; Campbell, MJ; Leathem, AJC; Woodside, JV; (2002) In vitro isoflavone supplementation reduces hydrogen peroxide-induced DNA damage in sperm. TERATOGEN CARCIN MUT , 22 (3) 227 - 234. 10.1002/tcm.10015.

Simpson, AB; Calvert, PM; Sludden, JA; Boddy, AV; Griffin, MJ; Schatzlein, A; ... Twelves, CJ; + view all (2002) Topotecan in combination with carboplatin: phase I trial evaluation of two treatment schedules. ANN ONCOL , 13 (3) 399 - 402. 10.1093/annonc/mdf041.

Sinclair, AM; Bench, AJ; Bloor, AJC; Gottgens, JLB; Stanley, ML; Miller, J; ... Green, AR; + view all (2002) Rescue of the lethal scl(-/-) phenotype by the human SCL locus. BLOOD , 99 (11) 3931 - 3938.

Southworth, R; Dearling, JLJ; Medina, RA; Flynn, AA; Pedley, RB; Garlick, PB; (2002) Dissociation of glucose tracer uptake and glucose transporter distribution in the regionally ischaemic isolated rat heart: application of a new autoradiographic technique. EUR J NUCL MED MOL I , 29 (10) 1334 - 1341. 10.1007/s00259-002-0922-2.

Spanswick, VJ; Craddock, C; Sekhar, M; Mahendra, P; Shankaranarayana, P; Hughes, RG; ... Hartley, JA; + view all (2002) Repair of DNA interstrand crosslinks as a mechanism of clinical resistance to melphalan in multiple myeloma. BLOOD , 100 (1) 224 - 229. Green open access

Spanswick, VJ; Craddock, C; Sekhar, M; Mahendra, P; Shankaranarayana, P; Hughes, RG; ... Hartley, JA; + view all (2002) Repair of DNA interstrand crosslinks as a mechanism of clinical resistance to melphalan in multiple myeloma. Blood , 100 (1) 224 - 229.

Spencer, DI; Robson, L; Purdy, D; Whitelegg, NR; Michael, NP; Bhatia, J; ... Chester, KA; + view all (2002) A strategy for mapping and neutralizing conformational immunogenic sites on protein therapeutics. Proteomics , 2 (3) 271 - 279.

Spencer, DIR; Robson, L; Purdy, D; Whitelegg, NR; Michael, NP; Bhatia, J; ... Chester, KA; + view all (2002) A strategy for mapping and neutralizing conformational immunogenic sites on protein therapeutics. PROTEOMICS , 2 (3) 271 - 279.

Standish, R; Dhillon, A; Gibson, A; Jenkins, J; Difford, J; Savage, K; ... Dhillon, A; + view all (2002) The assessment of fibrosis in liver biopsies from patients with chronic HBV infection - Image analysis vs Ishak stage score. Journal of Hepatology , 36 986 - ?.

Starke, R; Drummond, O; MacGregor, I; Biggerstaff, J; Gale, R; Camilleri, R; ... Harrison, P; + view all (2002) The expression of prion protein by endothelial cells: a source of the plasma form of prion protein? BRIT J HAEMATOL , 119 (3) 863 - 873.

Starke, R; Gale, R; Camilleri, R; Mackie, I; Machin, S; Harrison, P; ... Biggerstaff, J; + view all (2002) The expression of prion protein by endothelial cells: A source of the plasma form of prion protein? British Journal of Haematology , 119 (3) 863 - 873. 10.1046/j.1365-2141.2002.03847.x.

Steele, JPC; Shamash, J; Barlow, CS; Evans, MT; Gower, NH; Rudd, RM; (2002) Phase II trial of irinotecan, cisplatin and mitomycin C (IPM) in malignant pleural mesothelioma. In: Proceedings of Association of the American Society of Clinical Oncology. (pp. 1227 - ?).

Stephan, DA; Howell, GR; Teslovich, TM; Coffey, AJ; Smith, L; Bailey-Wilson, JE; ... Trent, JM; + view all (2002) Physical and transcript map of the hereditary prostate cancer region at Xq27. GENOMICS , 79 (1) 41 - 50. 10.1006/geno.2001.6681.

Stephens, RJ; Brown, JM; Fairlamb, DJ; Gower, N; Maslove, L; Milroy, R; ... Waller, D; + view all (2002) The big lung trial (BLT): Determining the value of cisplatin- based chemotherapy for all patients with non-small cell lung cancer (NSCLC). Preliminary results in the supportive care setting. British Journal of Cancer , 86 S2 - S2.

Stephens, RJ; Fairlamb, DJ; Gower, NH; Maslove, L; Milroy, R; Napp, V; ... Waller, D; + view all (2002) The Big Lung Trial (BLT): determining the value of cisplatin based chemotherapy for all patients with non-small cell lung cancer (NSCLC). In: Proceedings of Association of the American Society of Clinical Oncology. (pp. 1161 - ?).

Stephens, RJ; Gower, NH; Napp, V; Rudd, RM; Spiro, SG; Thorpe, H; (2002) On behalf of the BLT Steering Committee and Participants: The big lung trial (BLT): a major randomised trial examining the role of cisplatin-based chemotherapy in all stages of non-small cell lung cancer (NSCLC). In: European Respiratory Journal. (pp. 399 - ?).

Stubbs, M; Khan, K; Savage, K; Grimes, S; Michaeli, D; Dhillon, AP; ... Caplin, M; + view all (2002) Correlation between uptake of labelled anti-CCKB/gastrin receptor antibodies and the occurrence of apoptosis in hepatoma cell lines. GASTROENTEROLOGY , 122 (4) A380 - A380.

Sugie, K; Yamamoto, A; Murayama, K; Nonaka, I; Nishino, I; Oh, SJ; ... Hirano, M; + view all (2002) Clinicopathological features of genetically-confirmed Danon disease. Journal of the Neurological Sciences , 199 S105 - S105.

Sugie, K; Yamamoto, A; Murayama, K; Takahashi, M; Mora, M; Riggs, JE; ... Nishino, I; + view all (2002) Clinicopathological features of genetically confirmed Danon disease. Neurology , 58 (12) 1773 - 1778.


Tamames, J; Clark, D; Herrero, J; Dopazo, J; Blaschke, C; Fernández, JM; ... Valencia, A; + view all (2002) Bioinformatics methods for the analysis of expression arrays: data clustering and information extraction. Journal of Biotechnology , 98 (2-3) 269 - 283. 10.1016/S0168-1656(02)00137-2.

Tchilian, EZ; Dawes, R; Ramaley, PA; Whitworth, JA; Yuldasheva, N; Wells, RS; ... Beverley, PCL; + view all (2002) A CD45 polymorphism associated with abnormal splicing is absent in African populations. IMMUNOGENETICS , 53 (10-11) 980 - 983. 10.1007/s00251-001-0410-z.

Thomas, HD; Porter, DJ; Bartelink, I; Nobbs, JR; Cole, M; Elliott, S; ... Boddy, AV; + view all (2002) Randomized cross-over clinical trial to study potential pharmacokinetic interactions between cisplatin or carboplatin and etoposide. BRIT J CLIN PHARMACO , 53 (1) 83 - 91.

Thyagarajan, D; Byrne, E; (2002) Mitochondrial disorders of the nervous system: Clinical, biochemical, and molecular genetic features. Mitochondrial Function and Dysfunction , 53 93 - 144.

Tiercy, JM; Marsh, SGE; Schreuder, GMTH; Albert, E; Fischer, G; Wassmuth, R; (2002) Guidelines for nomenclature usage in HLA reports: ambiguities and conversion to serotypes. European Journal of Immunogenetics , 29 273 - 274.

Tipping, AJ; Mahon, FX; Zafirides, G; Lagarde, V; Goldman, JM; Melo, JV; (2002) Drug responses of imatinib mesylate-resistant cells: synergism of imatinib with other chemotherapeutic drugs. LEUKEMIA , 16 (12) 2349 - 2357. 10.1038/sj.leu.2402775.

Toth, JL; Price, CA; Madsen, EC; Handl, HL; Hudson, SJ; Hubbard, RB; ... Lee, M; + view all (2002) Sequence selective recognition of DNA by hairpin conjugates of a racemic seco-cyclopropaneindoline-2-benzofurancarboxamide and polyamides. BIOORG MED CHEM LETT , 12 (16) 2245 - 2248.

Toth, JL; Price, CA; Madsen, EC; Handl, HL; Hudson, SJ; Hubbard, RB; ... Lee, M; + view all (2002) Sequence selective recognition of DNA by hairpin conjugates of a racemic seco-cyclopropaneindoline-2-benzofurancarboxamide and polyamides. Bioorg Med Chem Lett , 12 (16) 2245 - 2248.

Tracey, L; Villuendas, R; Ortiz, P; Dopazo, A; Spiteri, I; Lombardia, L; ... Piris, MA; + view all (2002) Identification of genes involved in resistance to interferon-alpha in cutaneous T-cell lymphoma. Am J Pathol , 161 (5) 1825 - 1837.

Tsuzuki, S; Enver, T; (2002) Interactions of GATA-2 with the promyelocytic leukemia zinc finger (PLZF) protein, its homologue FAZF, and the t(11;17)-generated PLZF-retinoic acid receptor alpha oncoprotein. BLOOD , 99 (9) 3404 - 3410.

Tsuzuki, S; Enver, T; Zelent, A; (2002) Ligand dependent potentiation of GATA-2 activity through interaction with retinoic acid receptors. In: BLOOD. (pp. 718A - 718A). AMER SOC HEMATOLOGY


Vassileva, V; Millar, A; Briollais, L; Chapman, W; Bapat, B; (2002) Genes involved in DNA repair are mutational targets in endometrial cancers with microsatellite instability. CANCER RES , 62 (14) 4095 - 4099.

Venables, K; Winfield, E; Aird, E; Hoskin, PJ; (2002) Three-dimensional distribution of radiation within the breast: an intercomparison of departments participating in the START trial of breast radiotherapy fractionation. International Journal of Radiation Oncology Biology Physics , 55 271 - 279.

Verfuerth, S; Pizzey, AR; Geary, J; Thomas, AC; Peggs, KS; Mackinnon, S; (2002) Magnetic sorting of gamma-IFN-producing T lymphocytes following in vitro restimulations by CMV antigen-pulsed dendritic cells results in a much more diverse range of CMV-specific T cells than CMV-pp65-HLA tetramer selection. In: BLOOD. (pp. 173A - 173A). AMER SOC HEMATOLOGY

Vichinsky, E; Harmatz, P; Fung, E; Madden, J; Louie, L; Walter, PB; ... Porter, J; + view all (2002) Secondary hemochromatosis in Bthalassemia and sickle cell disease. In: BLOOD. (pp. 24B - 24B). AMER SOC HEMATOLOGY

Vinall, LE; King, M; Novelli, M; Green, CA; Daniels, G; Hilkens, J; ... Swallow, DM; + view all (2002) Altered expression and allelic association of the hypervariable membrane mucin MUC1 in Helicobacter pylori gastritis. GASTROENTEROLOGY , 123 (1) 41 - 49. 10.1053/gast.2002.34157.

Virchis, A; Ganeshaguru, K; Hart, S; Jones, D; Fletcher, L; Wright, F; ... Mehta, A; + view all (2002) A novel treatment approach for low grade lymphoproliferative disorders using PKC412 (CGP41251), an inhibitor of protein kinase C. Hematol J , 3 (3) 131 - 136. 10.1038/sj.thj.6200165.


Wald, NJ; Hackshaw, AK; (2002) Folic acid supplementation and neural tube defects. AM J MED GENET , 109 (1) 79 - 79. 10.1002/ajmg.10292.

Wald, NJ; Huttly, W; Hackshaw, AK; (2002) Antenatal screening policies for Down's syndrome - Audit of Down's syndrome screening is not valid. BRIT MED J , 325 (7371) 1034 - 1034.

Wanless, IR; Sweeney, G; Dhillon, AP; Guido, M; Piga, A; Galanello, R; ... Cohen, AR; + view all (2002) Lack of progressive hepatic fibrosis during long-term therapy with deferiprone in subjects with transfusion-dependent beta-thalassemia. BLOOD , 100 (5) 1566 - 1569. 10.1182/blood-2002-01-0306.

Ward, KN; White, RP; Mackinnon, S; Hanna, M; (2002) Human herpesvirus-7 infection of the CNS with acute myelitis in an adult bone marrow recipient. BONE MARROW TRANSPL , 30 (12) 983 - 985. 10.1038/sj.bmt.1703774.

Waterston, RH; Lindblad-Toh, K; Birney, E; Rogers, J; Abril, JF; Agarwal, P; ... Mouse Genome Sequencing Consor,; + view all (2002) Initial sequencing and comparative analysis of the mouse genome. NATURE , 420 (6915) 520 - 562. 10.1038/nature01262.

Watt, DJ; Jones, GE; Goldring, K; (2002) The involvement of galectin-1 in skeletal muscle determination, differentiation and regeneration. GLYCOCONJUGATE J , 19 (7-9) 615 - 619.

Watts, MJ; Somervaille, TC; Ings, SJ; Ahmed, F; Khwaja, A; Yong, K; Linch, DC; (2002) Variable product purity and functional capacity after CD34 selection: a direct comparison of the CliniMACS (v2.1) and Isolex 300i (v2.5) clinical scale devices. Br J Haematol , 118 (1) 117 - 123.

Watts, MJ; Somervaille, TCP; Ings, SJ; Ahmed, F; Khwaja, A; Linch, DC; (2002) Isolex 300i and CliniMACS clinical scale CD34 selection devices: A split harvest comparison. LEUKEMIA , 16 (3) 416 - 416.

Watts, MJ; Somervaille, TCP; Ings, SJ; Ahmed, F; Khwaja, A; Yong, K; Linch, DC; (2002) Variable product purity and functional capacity after CD34 selection: a direct comparison of the CliniMACS((R)) (v2 center dot 1) and Isolex((R)) 300i (v2 center dot 5) clinical scale devices. BRIT J HAEMATOL , 118 (1) 117 - 123.

Westin, J; Lagging, LM; Spak, F; Aires, N; Svensson, E; Lindh, M; ... Wejstal, R; + view all (2002) Moderate alcohol intake increases fibrosis progression in untreated patients with hepatitis C virus infection. J VIRAL HEPATITIS , 9 (3) 235 - 241.

Whelan, JS; Burcombe, RJ; Janinis, J; Baldelli, AM; Cassoni, AM; (2002) A systematic review of the role of pulmonary irradiation in the management of primary bone tumours. Ann Oncol , 13 (1) 23 - 30.

Woo, YL; Allard, S; Cohen, H; Letsky, E; de Swiet, M; (2002) Danaparoid thromboprophylaxis in pregnant women with heparin-induced thrombocytopenia. BJOG-INT J OBSTET GY , 109 (4) 466 - 468.


Yaguchi, H; Ohkura, N; Tsukada, T; Yamaguchi, K; (2002) Menin, the multiple endocrine neoplasia type 1 gene product, exhibits GTP-hydrolyzing activity in the presence of the tumor metastasis suppressor nm23. J Biol Chem , 277 (41) 38197 - 38204. 10.1074/jbc.M204132200. Gold open access

Yates, F; Malassis-Séris, M; Stockholm, D; Bouneaud, C; Larousserie, F; Noguiez-Hellin, P; ... Cavazzana-Calvo, M; + view all (2002) Gene therapy of RAG-2-/- mice: sustained correction of the immunodeficiency. Blood , 100 (12) 3942 - 3949. 10.1182/blood-2002-03-0782.

Yee, TT; Beeton, K; Griffioen, A; Harrington, C; Miners, A; Lee, CA; Brown, SA; (2002) Experience of prophylaxis treatment in children with severe haemophilia. HAEMOPHILIA , 8 (2) 76 - 82.

Yee, TT; Griffioen, A; Subel, B; Dusheiko, G; Patch, D; Lee, CA; (2002) HCV treatment in a cohort of patients with inherited bleeding disorders. In: ANTIVIRAL THERAPY. (pp. L125 - L126). INT MEDICAL PRESS LTD

Yong, KL; Fahey, A; Pahal, G; Linch, DC; Pizzey, A; Thomas, NSB; ... Thrasher, AJ; + view all (2002) Fetal haemopoietic cells display enhanced migration across endothelium. BRIT J HAEMATOL , 116 (2) 392 - 400.

Yong, KL; Fahey, A; Pizzey, A; Linch, DC; (2002) Influence of cell cycling and cell division on transendothelial migration of CD34(+) cells. BRIT J HAEMATOL , 119 (2) 500 - 509.


Zhang, J; Vanhaesebroeck, B; Rittenhouse, SE; (2002) Human platelets contain p110 delta phosphoinositide 3-kinase. BIOCHEM BIOPH RES CO , 296 (1) 178 - 181.

Ziegler, A; Beck, S; Ehlers, A; Younger, R; Volz, A; (2002) Testicular transcripts of HLA-linked olfactory receptor genes exhibit exon sharing and extensive long-distance alternative splicing. TISSUE ANTIGENS , 59 39 - 40.

This list was generated on Sun Jul 5 04:37:08 2015 BST.